Clomiphene Citrate vs Gonadorelin
A side-by-side research comparison of Clomiphene Citrate and Gonadorelin across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Clomiphene Citrate | Gonadorelin |
|---|---|---|
| Full name | Clomiphene Citrate (Clomid) | Gonadorelin (GnRH Analog) |
| Category | Hormone Replacement | Hormone Replacement |
| Status | FDA Approved (off-label for men) | FDA Approved |
| Mechanism | Blocks estrogen receptors in the hypothalamus, preventing negative feedback. This increases GnRH pulsatility, elevating pituitary LH and FSH output and subsequently testicular testosterone production. | Binds GnRH receptors on pituitary gonadotrophs to stimulate LH and FSH release, maintaining testicular/ovarian function and natural sex hormone production. |
| Molecular weight | 598.09 Da (citrate salt) | 1182.39 Da |
| Half-life | ~5-7 days | ~10-40 minutes |
| Bioavailability | ~80% oral | ~90% subcutaneous |
| Typical dose | 12.5-50 mg | 100-500 mcg |
| Frequency | Daily or every other day | 2-3x per week or pulsatile |
| Route | Oral | Subcutaneous injection |
Clomiphene Citrate reported benefits
- Increased endogenous testosterone
- Preserved fertility
- Elevated LH/FSH
- No testicular atrophy
- Improved sperm parameters
Gonadorelin reported benefits
- Maintains natural hormone production
- Fertility preservation
- Testicular function support
- LH/FSH normalization
Related comparisons
Research and educational reference only. Not medical advice.